Meta Information

ID:triim-protocol

Name:TRIIM Protocol

Schema Version:1.5

Alternate Names

• Thymus Regeneration, Immunorestoration, and Insulin Mitigation

Intervention Type

protocol

Expected Cost Mean

Low Cost:

1100

High Cost:

3100

Cost Type:

monthly

Description:

Cost is primarily driven by prescription recombinant human growth hormone (rhGH).

Summary

The TRIIM protocol combines several agents to regenerate the thymus gland, a key organ for adaptive immunity that shrinks with age. By using growth hormone to stimulate thymic tissue and metformin/DHEA to mitigate GH's pro-aging metabolic effects, it aims to reverse immunosenescence. A small pilot study showed a significant reversal of epigenetic age, suggesting a potential systemic rejuvenation effect.

Purpose

A multi-drug protocol to regenerate the thymus and reverse immunosenescence.

Card Summary

A multi-drug protocol combining growth hormone, DHEA, and metformin to regenerate the thymus gland, aiming to reverse age-related immune decline (immunosenescence).

Drug Class

Drugs In Class

Empty Array

Impact

Score:

3.8

Justification:

Potentially profound epigenetic age reversal, but based on a single small pilot study.

Evidence

Grade:

B

Score:

4.5

Justification:

Based on a single, small, non-randomized human pilot study (the TRIIM trial).

Safety

Score:

7.5

Justification:

Requires intensive medical supervision due to off-label use of multiple prescription drugs.

Flags

• Requires a prescription and close monitoring by a qualified physician.
• Human Growth Hormone (hGH) is a controlled substance in many regions.
• The foundational study was very small and lacked a placebo control group.
• Long-term safety and efficacy for longevity purposes are unknown.
• Potential for significant side effects from individual components (e.g., hGH, Metformin).

Verdict

Highly experimental protocol with profound potential but very limited human data.

Created

2026-04-24T00:31:46.258671Z

Model

Gemini 3.1 Pro (High)

Delivery

Route:

none

Scope:

• systemic

Indication

Focus:

healthspan

Description:

The TRIIM protocol combines several agents to regenerate the thymus gland, a key organ for adaptive immunity that shrinks with age. By using growth hormone to stimulate thymic tissue and metformin/DHE...

Typical Protocol

• A one-year protocol combining weekly injections of recombinant human growth hormone (rhGH) with daily oral DHEA, Metformin, Zinc, and Vitamin D3 under strict medical supervision.